Quick Takeaways
- FEDERATED HERMES, INC. filed SCHEDULE 13G/A for EYEPOINT PHARMACEUTICALS, INC. COMMON STOCK (EYPT).
- Disclosed ownership: 6.7%.
- Date of event: 30 Jun 2025.
FEDERATED HERMES, INC. - 30 Jun 2025 SCHEDULE 13G/A Report for EYEPOINT PHARMACEUTICALS, INC. COMMON STOCK (EYPT)
- Filing Manager
- FEDERATED HERMES, INC.
- Reporting Manager
- Federated Hermes, Inc.
- Symbol
- EYPT
- Shares outstanding
- 68,854,042 shares
- Disclosed Ownership
- 4,599,450 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Jul 2025, 07:30:44 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FEDERATED HERMES, INC. disclosed 6.7% ownership in EYEPOINT PHARMACEUTICALS, INC. COMMON STOCK (EYPT) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jul 2025, 07:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Federated Hermes, Inc. | 6.7% | 4,599,450 | 4,599,450 | 0 | /s/J. Christopher Donahue | J. Christopher Donahue, as President of Federated Hermes, Inc. | |
| Voting Shares Irrevocable Trust | 6.7% | 4,599,450 | 4,599,450 | 0 | /s/Thomas R. Donahue | Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust | |
| Thomas R. Donahue | 6.7% | 4,599,450 | 0 | 4,599,450 | /s/Thomas R. Donahue | Thomas R. Donahue | |
| Ann C. Donahue | 6.7% | 4,599,450 | 0 | 4,599,450 | /s/Ann C. Donahue | Ann C. Donahue | |
| J. Christopher Donahue | 6.7% | 4,599,450 | 0 | 4,599,450 | /s/J. Christopher Donahue | J. Christopher Donahue |